Drawing for OSTEOVET

USPTO serial 98956480

OSTEOVET

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SMITH, CYNTHIA RINALDI
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OSTEOVET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aaron D. Hendelman

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 Page Mill RoadPalo Alto, CA 94304United States

Goods and services

ClassDescriptionStatusFirst use
010Soft tissue regeneration matrices being surgical implants and mesh made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; bone implants composed of artificial materials; synthetic bone grafts; medical, surgical, and orthopedic implants made of artificial materials, namely, implantable scaffolds being fusion cages for spinal surgery and expandable spinal implants; implantable scaffolds comprising artificial materials for maintaining tissue contour; artificial bone parts to be implanted in natural bones to repair bone defects; artificial biomaterials for augmentation of bone for medical purposes, namely, synthetic materials for use in bone and joint surgery, bone regeneration, and bone reconstruction; synthetic implantable medical devices for the regeneration of bone defects, namely, bone void fillers comprised of artificial materials; implants consisting of artificial materials; implants comprising natural, non-living materials; artificial biomaterials for augmentation of tissue for medical purposes, namely, non-living tissue substitutes for use in human tissue repair, regeneration, and reconstruction; implants consisting of artificial materials to regenerate, repair, or treat soft tissue and bone; implants consisting of artificial materials for surgical repair, regeneration, reconstruction, and augmentation of human tissue; bone regeneration matrices being artificial biomaterials for augmentation of bone for medical purposes; surgical devices, apparatus, and instruments for use in bone and joint surgery, regeneration, reconstruction, and augmentationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 15, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 15, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 11, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 16, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 16, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 10, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 15, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 23, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 23, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 23, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 23, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2025DOCKASSIGNED TO EXAMINER—
Jun 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 13, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 13, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance